Utah Medical Products, Inc. (UTMD)

Utah Medical Products Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	93.81	92.87	75.05	60.97	51.59	42.79
Cash & Cash Equivalents	93.81	92.87	75.05	60.97	51.59	42.79
Cash Growth	15.94%	23.74%	23.09%	18.19%	20.57%	-16.29%
Receivables	3.59	3.39	5.54	5.13	4.1	4.74
Inventory	9.24	9.58	8.81	6.6	6.22	6.91
Other Current Assets	0.51	0.43	0.52	0.46	0.35	0.44
Total Current Assets	107.15	106.27	89.92	73.16	62.26	54.89
Property, Plant & Equipment	10.27	10.55	10.22	10.62	11.33	10.73
Goodwill and Intangibles	18.03	18.64	23.73	31.86	38.16	44.17
Total Long-Term Assets	28.29	29.19	33.96	42.48	49.48	54.9
Total Assets	135.44	135.46	123.87	115.64	111.75	109.79
Accounts Payable	1	0.77	1.22	0.76	0.79	1.1
Other Current Liabilities	4.48	3.94	4.74	2.98	3	2.35
Total Current Liabilities	5.47	4.71	5.96	3.75	3.79	3.45
Long-Term Debt	0.29	0.3	0.34	0.4	0.34	0.38
Other Long-Term Liabilities	1.94	2.14	3.32	4.36	4.8	4.87
Total Long-Term Liabilities	2.23	2.44	3.66	4.75	5.13	5.25
Total Liabilities	7.7	7.15	9.62	8.5	8.92	8.69
Total Debt	0.29	0.3	0.34	0.4	0.34	0.38
Debt Growth	-13.11%	-13.49%	-13.89%	18.21%	-10.90%	-
Retained Earnings	139	138.34	126.01	115.31	110.95	110.82
Comprehensive Income	-11.29	-10.66	-12.04	-9.05	-8.28	-9.78
Shareholders' Equity	127.74	128.31	114.25	107.14	102.82	101.09
Net Cash / Debt	93.52	92.57	74.71	60.58	51.26	42.41
Net Cash / Debt Growth	16.06%	23.91%	23.33%	18.19%	20.85%	-17.02%
Working Capital	101.68	101.56	83.96	69.41	58.47	51.44
Book Value Per Share	35.31	35.35	31.50	29.34	28.25	27.17

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).